| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Jun-30-10 | Dec-31-09 | Jun-30-09 | Dec-31-08 |
| | 10-K | 10-K | 10-K | 10-K | 8-K | 10-K/A | 8-K | 10-K |
| Revenues: |
| Actimmune | | | | | | | | 29.9 |
| Collaboration revenue | | | | | | | | 18.3 |
| Total revenues | 70.3 | 26.2 | 5.4 | 239.3 | 12.0 | 48.7 | 14.8 | 48.2 |
| Revenue growth [+] | 168.7% | 384.1% | -97.7% | 391.3% | -19.0% | 1.1% | | -27.8% |
| Actimmune | | | | | | | | -44.1% |
| Collaboration revenue | | | | | | | | 37.7% |
| Cost of goods sold | 10.4 | 8.9 | 1.4 | 0.0 | 3.8 | 7.0 | 4.5 | 9.0 |
| Gross profit | 59.9 | 17.3 | 4.0 | 239.3 | 8.2 | 41.7 | 10.2 | 39.2 |
| Gross margin | 85.2% | 65.9% | 74.0% | 100.0% | 68.2% | 85.6% | 69.3% | 81.3% |
| Selling, general and administrative [+] | 145.1 | 105.3 | 89.5 | 55.0 | 27.9 | 37.5 | 17.2 | 30.6 |
| General and administrative | | | | | 27.9 | | 17.2 | 30.6 |
| Research and development | 113.5 | 106.6 | 75.0 | 67.5 | 35.2 | 89.1 | 47.4 | 104.2 |
| Other operating expenses | | | | | | 15.3 | 13.5 | |
| EBITDA [+] | -195.9 | -192.4 | -158.5 | 119.2 | | -96.6 | | -92.1 |
| EBITDA growth | 1.8% | 21.4% | -233.0% | -223.4% | | 4.8% | | 32.5% |
| EBITDA margin | -278.4% | -735.1% | -2931.6% | 49.8% | | -198.3% | | -191.3% |
| Depreciation | 1.8 | 1.2 | 1.1 | 2.4 | | 3.6 | | 3.6 |
| EBITA | -197.6 | -193.6 | -159.6 | 116.8 | -54.9 | -100.1 | -67.8 | -95.7 |
| EBITA margin | -281.0% | -739.7% | -2952.4% | 48.8% | -458.5% | -205.6% | -458.7% | -198.7% |
| Amortization of intangibles | 1.0 | 1.0 | 0.8 | | | | | |
| EBIT [+] | -198.6 | -194.6 | -160.4 | 116.8 | -54.9 | -100.1 | -67.8 | -95.7 |
| EBIT growth | 2.1% | 21.3% | -237.4% | -216.6% | -19.0% | 4.7% | | -1.0% |
| EBIT margin | -282.4% | -743.5% | -2967.2% | 48.8% | -458.5% | -205.6% | -458.7% | -198.7% |
| Non-recurring items | | | | 1.3 | 1.3 | 0.7 | 0.7 | |
| Interest expense, net [+] | 14.2 | 8.3 | 5.9 | 7.8 | 3.9 | 8.4 | 4.1 | 7.5 |
| Interest expense | 14.6 | 8.9 | 6.4 | 8.4 | 4.2 | 10.1 | 5.2 | 13.2 |
| Interest income | 0.4 | 0.6 | 0.6 | 0.6 | 0.3 | 1.7 | 1.2 | 5.6 |
| Other income (expense), net [+] | -7.1 | -0.4 | -0.7 | 1.6 | 0.6 | -4.6 | -3.9 | -3.4 |
| Gain (loss) on debt retirement | -7.9 | | | | | -11.0 | | -1.3 |
| Other | -1.6 | -0.4 | -0.7 | 1.6 | | 6.4 | | 2.1 |
| Pre-tax income | -219.9 | -203.3 | -166.9 | 109.2 | -59.4 | -113.9 | -76.5 | -106.6 |
| Income taxes | 0.9 | -18.6 | -4.6 | 0.1 | 0.0 | 2.2 | 2.2 | 0.0 |
| Tax rate | | 9.2% | 2.8% | 0.1% | 0.0% | | | 0.0% |
| Earnings from continuing ops | -220.8 | -184.7 | -162.4 | 109.2 | | -116.0 | | -106.6 |
| Earnings from discontinued ops | 1.2 | 34.6 | 7.6 | 13.2 | | | | -106.5 |
| Net income | -219.6 | -150.1 | -154.8 | 122.4 | -59.4 | -116.0 | -78.7 | -213.1 |
| Net margin | -312.2% | -573.4% | -2862.5% | 51.1% | -496.3% | -238.2% | -532.4% | -442.5% |
| |
| Basic EPS [+] | ($2.71) | ($2.83) | ($2.70) | $2.01 | $0.00 | ($2.62) | $0.00 | ($2.73) |
| Growth | -4.3% | 4.9% | -234.1% | -177.0% | | -4.3% | | -7.6% |
| Diluted EPS [+] | ($2.71) | ($2.83) | ($2.70) | $1.78 | $0.00 | ($2.62) | $0.00 | ($2.73) |
| Growth | -4.3% | 4.9% | -251.9% | -168.0% | | -4.3% | | -7.6% |
| |
| Shares outstanding (basic) [+] | 81.4 | 65.2 | 60.1 | 54.2 | 53.4 | 44.3 | 43.0 | 39.0 |
| Growth | 24.9% | 8.5% | 10.9% | 22.2% | 24.2% | 13.8% | | 9.8% |
| Shares outstanding (diluted) [+] | 81.4 | 65.2 | 60.1 | 61.4 | 53.4 | 44.3 | 43.0 | 39.0 |
| Growth | 24.9% | 8.5% | -2.1% | 38.4% | 24.2% | 13.8% | | 9.8% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |